Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Ventana to create a companion diagnostic for Millennium/Seattle Genetics' Adcetris

Executive Summary

Roche’s cancer diagnostics division Ventana Medical Systems Inc. has agreed to develop, manufacture, and sell a molecular companion diagnostic that would be used in the treatment planning for Adcetris (brentuximab vedotin), a lymphoma therapy developed by Seattle Genetics Inc. and Millennium: The Takeda Oncology Co.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies